ACVx

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameACVx

Drug Alias NameACV-1 oral analog (Metabolic Pharmaceuticals)synthetic Vc1.1a peptide analog (Metabolic Pharmaceuticals)conotoxin peptide (Metabolic Pharmaceuticals)nicotinic acetyl choline receptor antagonist (Metabolic Pharmaceuticals)

ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Toxin

Mechanisms of ActionNicotinic receptors antagonists

TargetsNicotinic receptors

Therapy Area/IndicationsNeuralgia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPolynovo

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPolynovo

Active IndicationsN/A

Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A